Home › Philanthropy, voluntarism & grantmaking
The Ovarian Cancer Research Fund
Also known as Ovarian Cancer Research Alliance
The Ovarian Cancer Research Fund reported $19.5 million in revenue and $17.3 million in expenses for calendar year 2025. Of every $100 it spent, $81.94 went to program services, $6.79 to management and general costs and $11.27 to fundraising. Its largest source of revenue was contributions and grants: 91.4% of the total. The highest compensation it reported for one person was $368,755 (PRESIDENT & CEO). 13 people received more than $100,000 in reportable compensation. Revenue rose 132% between 2019 and 2025. Source: Form 990, 2025.
Where $100 of spending went
Calendar year 2025 · Form 990, Part IX, line 25 · total expenses $17MFor context, the median across 1,001 covered philanthropy, voluntarism & grantmaking charities: $91.65 programs, $6.50 management, $1.85 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
Calendar year 2025 · Form 990, Part VIII · total revenue $20MOther revenue was negative: −$77,316. The bar shows the positive sources only.
The 990 scorecard · same measures for every charity, no grades
| Measure | 2025 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 81.9% | 90.2% |
| Management & general Part IX 25(C) ÷ 25(A) | 6.8% | 6.4% |
| Fundraising Part IX 25(D) ÷ 25(A) | 11.3% | 1.8% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | $0.11 | $0.02 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 91.4% | 79.9% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 0.0% | 0.0% |
| Program service revenue share Part VIII 2g ÷ 12 | 0.0% | 0.0% |
| Highest reported compensation Part VII-A, columns D–F | $368,755 | $325,675 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 2.13% | 1.56% |
| People paid over $100,000 Part VII, line 2 | 13 | 3 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 18.7 | 56.6 |
| Independent voting board members Part VI 1a–1b | 18 of 18 | 100.0% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
2025 · Form 990, Part III · the three largest programs by expenseOvarian Cancer Research alliance was founded in 1994 (as the Ovarian Cancer Research Fund, inc.) and is a full-spectrum organization funding medical research, advocating on behalf of patients and providing support and resources to patients and their families.Ovarian Cancer is the deadliest of all gynecologic cancers and ranks fifth as the cause of cancer death in women. In 2025, there were 20,890 new cases of Ovarian Cancer and 12,730 deaths from the disease in the united states. The accomplishments of ocra's programs reflect our commitment to the ovarian and gynecologic cancer communities.…
In 2025, Ovarian Cancer Research alliance (ocra) provided comprehensive education, support, and navigation services to thousands of individuals affected by ovarian and gynecologic cancers. Ocra's patient support team responded to 4,237 patient and caregiver contacts through our patient support line, a 68% increase from 2024, providing emotional support, information, clinical trial guidance, peer mentoring, and care navigation. Ocra's woman to woman peer mentor program continued to connect newly diagnosed patients with trained survivor mentors through 19 active sites nationwide and a national…
Ovarian Cancer Research alliance is a powerful voice on capitol hill, in statehouses around the country and with federal agencies for everyone touched by gynecologic cancer. In 2025, ocra established its center for public policy to expand policy education, legislative tracking, and advocacy engagement opportunities for patients, caregivers, and supporters nationwide. Ocra trained and mobilized more than 160 advocates and supporters to engage in the policymaking process. Nearly 120 advocates from 35 states and the district of columbia participated in ocra's advocacy day, conducting more than…
Highest reported compensation
2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| PRESIDENT & CEO Officer, 40.00 hrs/week | $333,548 | $0 | $35,207 | $368,755 |
| CHIEF DEVELOPMENT OFFICER Key employee, 40.00 hrs/week | $201,949 | $0 | $43,479 | $245,428 |
| CHIEF PROGRAM OFFICER Key employee, 40.00 hrs/week | $171,149 | $0 | $69,876 | $241,025 |
| VICE PRESIDENT, SUPPORT & EDUCATION Highest compensated employee, 40.00 hrs/week | $162,573 | $0 | $28,215 | $190,788 |
| VP - PHILANTHROPIC PARTNER Highest compensated employee, 40.00 hrs/week | $109,257 | $0 | $64,705 | $173,962 |
| FORMER CHIEF FINANCIAL OFFICER Former, 0.00 hrs/week | $157,000 | $0 | $0 | $157,000 |
| VICE PRESIDENT, POLICY Highest compensated employee, 40.00 hrs/week | $126,974 | $0 | $26,691 | $153,665 |
| TREATMENT ACCESS & SCIENTIFIC EDUCATION Highest compensated employee, 40.00 hrs/week | $145,000 | $0 | $4,085 | $149,085 |
13 people received more than $100,000 in reportable compensation from The Ovarian Cancer Research Fund (Part VII, line 2). Compensation of current officers, directors and key employees totaled $855K (Part IX, line 5).
7 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b18 · 18 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4Yes
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bYes
- Employees Part I, line 529
- Volunteers Part I, line 61,937
Largest outside contractors
2025 · Form 990, Part VII, Section B · businesses only| CIRRO BIO INC Data support services | $450,000 |
| COSGROVE ACCOUNTING Accounting services | $233,127 |
| COLOR HEALTH Hereditary testing | $225,489 |
| ADC STRATEGIC COMMUNICATIONS Marketing & communication services | $220,766 |
| AMPLIFI Mailing services | $190,045 |
Individuals listed as contractors are left out. 9 contractors were paid more than $100,000 in all.
Private foundation grants it received
32 private foundations reported grants to The Ovarian Cancer Research Fund totaling $145K on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.
Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.
Correct a figure or respond
Every number above is copied from The Ovarian Cancer Research Fund's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for The Ovarian Cancer Research Fund, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 The Ovarian Cancer Research Fund spent in 2025, $81.94 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- York County Community FoundationYork, PA · revenue $19M · programs 83.5% · 2024
- Inland Southern California 211Riverside, CA · revenue $20M · programs 97.7% · FY2025
- United Way of Central OklahomaOklahoma City, OK · revenue $19M · programs 86.2% · 2024
- Momsrising Education FundBellevue, WA · revenue $20M · programs 95.4% · 2024
- United Way of Greater Philadelphia and Southern New JerseyPhiladelphia, PA · revenue $19M · programs 73.7% · FY2025
All philanthropy, voluntarism & grantmaking charities · Largest charities in New York
Questions people ask
How much of The Ovarian Cancer Research Fund's spending goes to programs?
In calendar year 2025, The Ovarian Cancer Research Fund reported that 81.9% of its $17.3 million in expenses went to program services, 6.8% to management and general and 11.3% to fundraising (Form 990, Part IX).
How much does The Ovarian Cancer Research Fund pay its top executive?
The largest total compensation The Ovarian Cancer Research Fund reported for one person in calendar year 2025 was $368,755, for the role of PRESIDENT & CEO (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does The Ovarian Cancer Research Fund get its money?
Of $19.5 million in revenue in calendar year 2025, 91.4% came from contributions and grants and 0.0% from program service revenue (Form 990, Part VIII).
Is The Ovarian Cancer Research Fund a registered charity?
The IRS lists EIN 13-3806788 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024, 2025. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- 2025: Form 990 for calendar year 2025, object 202602549349301565 · read the filing
- 2024: Form 990 for calendar year 2024, object 202533099349302348 · read the filing
- 2023: Form 990 for calendar year 2023 (amended), object 202523179349304572 · read the filing
- 2022: Form 990 for calendar year 2022, object 202323179349311082 · read the filing
- 2021: Form 990 for calendar year 2021, object 202223139349301237 · read the filing
- 2020: Form 990 for calendar year 2020, object 202103139349302350 · read the filing
- 2019: Form 990 for calendar year 2019, object 202043219349310614 · read the filing
All filings for EIN 13-3806788: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.